New ELISAs for detecting macroamylase or free autoantibodies to amylase were tested with 48 samples that had been characterized by gel chromatography and electrophoresis. The macroamylase ELISA, with anti-lgG or antiIgA for detection, detected macroamylase in 28 of 33 samples known to contain macroamylase (85% sensitivity), whereas the ELISA for free autoantibody to amylase was positive for only 11 samples. Specificities of both ELISAs were 93%. Among 28 true positives detected with the macroamylase ELISA, 22 contained IgA, 3 contained 
IndexingTerms: autoanfigens/autoimmune complexes
Macroenzymes, a form of enzymes with greater-thanexpected molecular mass, were first described in 1964 (1). The initial studies noted the occurrence in serum of amylase bound to globulin (1,2). Many subsequent publications describe the occurrence in serum of not only macroamylase (1-14), but also high-molecular-mass forms of many enzymes, including creatine kinase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase, lipase, alkaline phosphatase, and acid phosphatase (2-26). The most frequently recognized form of macroenzyme consists of a complex of an enzyme with an autoantibody directed against it. Other less frequent types of macroenzymes are oligomeric complexes, lipoproteinor glycoprotein-associated complexes, or, in the case of amylase, complexes of amylase bound to substrate analogs such as dextrans and hydroxyethyl starches that are administered as volume expanders.
In macroenzymes consisting of enzyme-antibody complexes, the autoantibody frequently is monoclonal or oligoclonal. In most individuals with macroenzymes, the antibody is limited to a single class, IgG or A limitation of most methods is that they are manual and poorly suited for the analysis of large numbers of samples for population studies. The present study describes the use of ELISAs to detect either macroamylase or free autoantibody to amylase. These assays provide simple methods to screen large numbers of specimens, identi1r the class of autoantibody directed against amylase, and provide assessments of the occurrence of the autoantibody in free and antigen-complexed forms. reactions were stopped by adding 25 p1 of 3 mo]/L NaOH to each well, and absorbances were measured at 405 nm. Absorbance changes were standardized as multiples of the value in the same run for a serum pool obtained from 10 subjects lacking macroamylase.
Materials and Methods

Materials
Gel filtration on columns of Sephacryl S-200 for detection of macroamylase was performed similarly to the method described by Fridhandler and Berk (4). Amylase activity was measured with a Technicon RA-1000 analyzer (Miles, Tarrytown, NY) with Beckman (Brea, CA) amylase DS reagents. Detection of macroamylase by electrophoresis was performed in Corning ACL agarose gels at pH 6.7, similarly to the method described by Gillard (27).
Linear regression
analyses of data were performed with InPiot software (GraphPad, San Diego, CA).
Results
Optimizationof ELISAs
Sensitivity of the ELISA methods for detection of both macroenzyme complex and free autoantibody to amylase was optimized for various components of the assay.
Specific
binding was assessed by using two specimens with significant amounts of both macroamylase and free autoantibody to amylase. Nonspecific binding (background) was evaluated by using two specimens containing high amylase activity but no macroamylase. The goal was to maximize the ratio of absorbance from specific binding to background absorbance. 
Precision of Assays
The within-run precision of the ELISAs was assessed by repeatedly analyzing a specimen known to contain both macroamylase and free autoantibodies 
DIscussIon
The present study offers new methods to screen specimens for macroamylase and autoantibodies to amylase based on ELISA technology.
Comparison with gel ifitration and electrophoresis indicates that 85% of samples with macroamylase can be detected by ELISA, with a specificity of 93%. Because the ELISA detects only macroamylases consisting of antibody-amylase complexes, macroamylases associated with other macromolecules such as dextrans and hydroxyethyl starch will be negative in the ELISA. Other potential causes of false negatives are dissociation of antibody-amylase complexes formed with low-affinity antibody during the multiple washing steps or overlap of the epitope recognized by the autoantibody with the site bound by the capture antiserum.
The occurrence of macroenzymes containing low-affinity antibodies may explain the low sensitivity in detecting the macroamylases that were positive by gel filtration but negative by electrophoresis.
An ELISA could also fail to detect macroamylases consisting of complexes with less abundant classes of antibody such as IgD or IgE, although these classes have not been reported as components of macroamylase.
Despite these limitations, the ELISA offers a rapid means for mass screening of sera for macroamylase, and, of the samples containing macroamylase >250 UJL, >95% will be detected. In the total group of samples examined, the sensitivity of the ELISA (85%) was similar to that of electrophoresis (87%).
Detection of macroamylases by ELISA techniques should identi1r macroamylases that are undetectable by assays relying on detection of amylase activity; these macroamylases are complexes containing antibodies that inhibit the enzyme activity of amylase. This may explain the occurrence of one sample that was strongly positive for macroamylase and autoantibody to amylase but negative for macroamylase by the activity-based reference methods. Results of the ELISAs for this sample may be classified incorrectly as false positives on the basis of shorthornings of the comparison methods, and the specificity of the ELISA may be underestimated as a consequence. The macroamylase ELISA identifies the class of antibody complexing with amylase to form macroamylase. The distribution of antibody class in the macroamylase cases examined was similar to that seen in previous studies (4-14). A higher proportion of macroamylases contain IgA than IgG antibodies, and relatively few macroamylases contain both IgA and IgG (4-14). Free autoantibody to amylase was detected in only about one-third of the samples containing macroamylase. This did not appear to be simply a matter of lower responsiveness of the ELISA to free antibody, because four samples with macroamylase yielded higher values in the assay for free antibody than in the assay for macroamylase, and several other samples yielded responses of nearly equal magnitude.
The lower positive detection rate of the ELISA for free autoantibody probably reflects lack of antibody excess in the majority of specimens containing macroamylase rather than a lower analytical sensitivity. In many cases, the binding sites of antibodies to amylase may be occupied fully by the antigen. An alternative explanation for low detection of free antibodies to amylase was that the antibodies were directed against pancreatic amylase rather than salivary amylase, which was used as the capture antigen. However, the high sequence homology of salivary and pancreatic amylases (34) and previous studies indicating that most macroamylases contain both pancreatic and salivary amylases (3-12) make this explanation unlikely. Testing a number of samples with pancreatic amylase as a capture antigen did not enhance the detection of positive samples (data not shown).
The gel filtration assay for detecting macroamylase provided evidence that most samples had antigen rather than antibody excess. The percentages of amylase activity as macroamylase and free amylase were determined, and most samples contained significant amounts of free amylase. Thirteen of 33 positive samples had 95% of amylase activity in the form of macroamylase, and 7 of these samples yielded a positive response in the ELISA for free antibody. Eleven of the 33 positive samples had <80% of amylase activity as macroamylase, and only one of these was positive in the ELISA for free antibody. These results suggest that the reason for the lower rates of positivity of the ELISA for free antibody than in the assay for macroamylase is that most samples containing macroamylase do not have antibody excess.
Comparison of the assays for macroamylase
and free autoantibody to amylase shows a much higher detection of anti-amylase autoimmunity with the assay for the macroenzyme.
These results may have important implications regarding optimal detection of other autoantibodies that are used as measures of autoimmunity.
Perhaps assaying for antigen-autoantibody complexes would improve the sensitivity of autoantibody detection, particularly during stages of active autoimmune attack of tissues containing the antigen, when there may be release of increased amounts of the antigen into the circulation.
Occurrence of macroenzymes generally has been considered as a separate phenomenon from the production of other autoantibodies.
However, this distinction, which has been based primarily on the mode of detection of macroenzymes, may be entirely artificial. 
Several clinically
